MedTrace Logo

Denervation of the renAl sympathetIc nerveS in hearT Failure With nOrmal Lv Ejection Fraction

NCT01583881 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-05-03

No results posted yet for this study

Summary

Increasing evidence suggests an important role of activation of the sympathetic nervous system (SNS) in the clinical phenomena of heart failure with normal left ventricular ejection fraction and hypertension. The current study aims to evaluate efficacy and safety of renal sympathetic denervation for the modulation of the SNS in patients with heart failure with normal LV ejection fraction.

Conditions

Interventions

PROCEDURE

renal denervation

Renal denervation

Sponsors & Collaborators

  • VU University of Amsterdam

    collaborator OTHER

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Michiel Voskuil, MD, PhD · UMC Utrecht

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-01
Primary Completion
2016-06-01
Completion
2016-07-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01583881 on ClinicalTrials.gov